Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Disease Control and Prevention Vaccine Market Growth 2022-2028

  • LP 4853463
  • 94 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Disease Control and Prevention Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Disease Control and Prevention Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Disease Control and Prevention Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Disease Control and Prevention Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Disease Control and Prevention Vaccine market, reaching US$ million by the year 2028. As for the Europe Disease Control and Prevention Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Disease Control and Prevention Vaccine players cover GSK, Merck & Co., Inc, Pfizer, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Disease Control and Prevention Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Live-Attenuated

Inactivated

Recombinant Sub Unit and Toxoid

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Pediatric Vaccine

Adult Vaccine

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GSK

Merck & Co., Inc

Pfizer

Sanofi

AstraZeneca PLC

Sinovac Biotech Ltd

Astellas Pharma Inc

Serum Institute of India Pvt. Ltd

Daiichi Sankyo

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Disease Control and Prevention Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Disease Control and Prevention Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Disease Control and Prevention Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Disease Control and Prevention Vaccine Segment by Type

2.2.1 Live-Attenuated

2.2.2 Inactivated

2.2.3 Recombinant Sub Unit and Toxoid

2.3 Disease Control and Prevention Vaccine Sales by Type

2.3.1 Global Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Disease Control and Prevention Vaccine Sale Price by Type (2017-2022)

2.4 Disease Control and Prevention Vaccine Segment by Application

2.4.1 Pediatric Vaccine

2.4.2 Adult Vaccine

2.5 Disease Control and Prevention Vaccine Sales by Application

2.5.1 Global Disease Control and Prevention Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Disease Control and Prevention Vaccine Sale Price by Application (2017-2022)

3 Global Disease Control and Prevention Vaccine by Company

3.1 Global Disease Control and Prevention Vaccine Breakdown Data by Company

3.1.1 Global Disease Control and Prevention Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Disease Control and Prevention Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Disease Control and Prevention Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Disease Control and Prevention Vaccine Revenue by Company (2020-2022)

3.2.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Disease Control and Prevention Vaccine Sale Price by Company

3.4 Key Manufacturers Disease Control and Prevention Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Disease Control and Prevention Vaccine Product Location Distribution

3.4.2 Players Disease Control and Prevention Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Disease Control and Prevention Vaccine by Geographic Region

4.1 World Historic Disease Control and Prevention Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Disease Control and Prevention Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Disease Control and Prevention Vaccine Annual Revenue by Geographic Region

4.2 World Historic Disease Control and Prevention Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Disease Control and Prevention Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Disease Control and Prevention Vaccine Annual Revenue by Country/Region

4.3 Americas Disease Control and Prevention Vaccine Sales Growth

4.4 APAC Disease Control and Prevention Vaccine Sales Growth

4.5 Europe Disease Control and Prevention Vaccine Sales Growth

4.6 Middle East & Africa Disease Control and Prevention Vaccine Sales Growth

5 Americas

5.1 Americas Disease Control and Prevention Vaccine Sales by Country

5.1.1 Americas Disease Control and Prevention Vaccine Sales by Country (2017-2022)

5.1.2 Americas Disease Control and Prevention Vaccine Revenue by Country (2017-2022)

5.2 Americas Disease Control and Prevention Vaccine Sales by Type

5.3 Americas Disease Control and Prevention Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Disease Control and Prevention Vaccine Sales by Region

6.1.1 APAC Disease Control and Prevention Vaccine Sales by Region (2017-2022)

6.1.2 APAC Disease Control and Prevention Vaccine Revenue by Region (2017-2022)

6.2 APAC Disease Control and Prevention Vaccine Sales by Type

6.3 APAC Disease Control and Prevention Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Disease Control and Prevention Vaccine by Country

7.1.1 Europe Disease Control and Prevention Vaccine Sales by Country (2017-2022)

7.1.2 Europe Disease Control and Prevention Vaccine Revenue by Country (2017-2022)

7.2 Europe Disease Control and Prevention Vaccine Sales by Type

7.3 Europe Disease Control and Prevention Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Disease Control and Prevention Vaccine by Country

8.1.1 Middle East & Africa Disease Control and Prevention Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Disease Control and Prevention Vaccine Sales by Type

8.3 Middle East & Africa Disease Control and Prevention Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Disease Control and Prevention Vaccine

10.3 Manufacturing Process Analysis of Disease Control and Prevention Vaccine

10.4 Industry Chain Structure of Disease Control and Prevention Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Disease Control and Prevention Vaccine Distributors

11.3 Disease Control and Prevention Vaccine Customer

12 World Forecast Review for Disease Control and Prevention Vaccine by Geographic Region

12.1 Global Disease Control and Prevention Vaccine Market Size Forecast by Region

12.1.1 Global Disease Control and Prevention Vaccine Forecast by Region (2023-2028)

12.1.2 Global Disease Control and Prevention Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Disease Control and Prevention Vaccine Forecast by Type

12.7 Global Disease Control and Prevention Vaccine Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Disease Control and Prevention Vaccine Product Offered

13.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Merck & Co., Inc

13.2.1 Merck & Co., Inc Company Information

13.2.2 Merck & Co., Inc Disease Control and Prevention Vaccine Product Offered

13.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck & Co., Inc Main Business Overview

13.2.5 Merck & Co., Inc Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Disease Control and Prevention Vaccine Product Offered

13.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Sanofi

13.4.1 Sanofi Company Information

13.4.2 Sanofi Disease Control and Prevention Vaccine Product Offered

13.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sanofi Main Business Overview

13.4.5 Sanofi Latest Developments

13.5 AstraZeneca PLC

13.5.1 AstraZeneca PLC Company Information

13.5.2 AstraZeneca PLC Disease Control and Prevention Vaccine Product Offered

13.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca PLC Main Business Overview

13.5.5 AstraZeneca PLC Latest Developments

13.6 Sinovac Biotech Ltd

13.6.1 Sinovac Biotech Ltd Company Information

13.6.2 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Offered

13.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sinovac Biotech Ltd Main Business Overview

13.6.5 Sinovac Biotech Ltd Latest Developments

13.7 Astellas Pharma Inc

13.7.1 Astellas Pharma Inc Company Information

13.7.2 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Offered

13.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Astellas Pharma Inc Main Business Overview

13.7.5 Astellas Pharma Inc Latest Developments

13.8 Serum Institute of India Pvt. Ltd

13.8.1 Serum Institute of India Pvt. Ltd Company Information

13.8.2 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Offered

13.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Serum Institute of India Pvt. Ltd Main Business Overview

13.8.5 Serum Institute of India Pvt. Ltd Latest Developments

13.9 Daiichi Sankyo

13.9.1 Daiichi Sankyo Company Information

13.9.2 Daiichi Sankyo Disease Control and Prevention Vaccine Product Offered

13.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Daiichi Sankyo Main Business Overview

13.9.5 Daiichi Sankyo Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Disease Control and Prevention Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Disease Control and Prevention Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live-Attenuated

Table 4. Major Players of Inactivated

Table 5. Major Players of Recombinant Sub Unit and Toxoid

Table 6. Global Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)

Table 7. Global Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2022)

Table 8. Global Disease Control and Prevention Vaccine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2017-2022)

Table 10. Global Disease Control and Prevention Vaccine Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)

Table 12. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2022)

Table 13. Global Disease Control and Prevention Vaccine Revenue by Application (2017-2022)

Table 14. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2017-2022)

Table 15. Global Disease Control and Prevention Vaccine Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Disease Control and Prevention Vaccine Sales by Company (2020-2022) & (K Units)

Table 17. Global Disease Control and Prevention Vaccine Sales Market Share by Company (2020-2022)

Table 18. Global Disease Control and Prevention Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Disease Control and Prevention Vaccine Revenue Market Share by Company (2020-2022)

Table 20. Global Disease Control and Prevention Vaccine Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Disease Control and Prevention Vaccine Producing Area Distribution and Sales Area

Table 22. Players Disease Control and Prevention Vaccine Products Offered

Table 23. Disease Control and Prevention Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Disease Control and Prevention Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Disease Control and Prevention Vaccine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Disease Control and Prevention Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Disease Control and Prevention Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Disease Control and Prevention Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Disease Control and Prevention Vaccine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Disease Control and Prevention Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Disease Control and Prevention Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Disease Control and Prevention Vaccine Sales by Country (2017-2022) & (K Units)

Table 35. Americas Disease Control and Prevention Vaccine Sales Market Share by Country (2017-2022)

Table 36. Americas Disease Control and Prevention Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Disease Control and Prevention Vaccine Revenue Market Share by Country (2017-2022)

Table 38. Americas Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)

Table 39. Americas Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2022)

Table 40. Americas Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)

Table 41. Americas Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2022)

Table 42. APAC Disease Control and Prevention Vaccine Sales by Region (2017-2022) & (K Units)

Table 43. APAC Disease Control and Prevention Vaccine Sales Market Share by Region (2017-2022)

Table 44. APAC Disease Control and Prevention Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Disease Control and Prevention Vaccine Revenue Market Share by Region (2017-2022)

Table 46. APAC Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)

Table 47. APAC Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2022)

Table 48. APAC Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)

Table 49. APAC Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2022)

Table 50. Europe Disease Control and Prevention Vaccine Sales by Country (2017-2022) & (K Units)

Table 51. Europe Disease Control and Prevention Vaccine Sales Market Share by Country (2017-2022)

Table 52. Europe Disease Control and Prevention Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country (2017-2022)

Table 54. Europe Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)

Table 55. Europe Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2022)

Table 56. Europe Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)

Table 57. Europe Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Disease Control and Prevention Vaccine Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Disease Control and Prevention Vaccine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Disease Control and Prevention Vaccine Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Disease Control and Prevention Vaccine Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Disease Control and Prevention Vaccine

Table 67. Key Market Challenges & Risks of Disease Control and Prevention Vaccine

Table 68. Key Industry Trends of Disease Control and Prevention Vaccine

Table 69. Disease Control and Prevention Vaccine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Disease Control and Prevention Vaccine Distributors List

Table 72. Disease Control and Prevention Vaccine Customer List

Table 73. Global Disease Control and Prevention Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Disease Control and Prevention Vaccine Sales Market Forecast by Region

Table 75. Global Disease Control and Prevention Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Disease Control and Prevention Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Disease Control and Prevention Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Disease Control and Prevention Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Disease Control and Prevention Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Disease Control and Prevention Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Disease Control and Prevention Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Disease Control and Prevention Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Disease Control and Prevention Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Disease Control and Prevention Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Disease Control and Prevention Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Disease Control and Prevention Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Disease Control and Prevention Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Disease Control and Prevention Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 93. GSK Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 94. GSK Disease Control and Prevention Vaccine Product Offered

Table 95. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. GSK Main Business

Table 97. GSK Latest Developments

Table 98. Merck & Co., Inc Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 99. Merck & Co., Inc Disease Control and Prevention Vaccine Product Offered

Table 100. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Merck & Co., Inc Main Business

Table 102. Merck & Co., Inc Latest Developments

Table 103. Pfizer Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 104. Pfizer Disease Control and Prevention Vaccine Product Offered

Table 105. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Pfizer Main Business

Table 107. Pfizer Latest Developments

Table 108. Sanofi Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 109. Sanofi Disease Control and Prevention Vaccine Product Offered

Table 110. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Sanofi Main Business

Table 112. Sanofi Latest Developments

Table 113. AstraZeneca PLC Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 114. AstraZeneca PLC Disease Control and Prevention Vaccine Product Offered

Table 115. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. AstraZeneca PLC Main Business

Table 117. AstraZeneca PLC Latest Developments

Table 118. Sinovac Biotech Ltd Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 119. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Offered

Table 120. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Sinovac Biotech Ltd Main Business

Table 122. Sinovac Biotech Ltd Latest Developments

Table 123. Astellas Pharma Inc Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 124. Astellas Pharma Inc Disease Control and Prevention Vaccine Product Offered

Table 125. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Astellas Pharma Inc Main Business

Table 127. Astellas Pharma Inc Latest Developments

Table 128. Serum Institute of India Pvt. Ltd Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 129. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Offered

Table 130. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Serum Institute of India Pvt. Ltd Main Business

Table 132. Serum Institute of India Pvt. Ltd Latest Developments

Table 133. Daiichi Sankyo Basic Information, Disease Control and Prevention Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 134. Daiichi Sankyo Disease Control and Prevention Vaccine Product Offered

Table 135. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Daiichi Sankyo Main Business

Table 137. Daiichi Sankyo Latest Developments

List of Figures

Figure 1. Picture of Disease Control and Prevention Vaccine

Figure 2. Disease Control and Prevention Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Disease Control and Prevention Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Disease Control and Prevention Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Disease Control and Prevention Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live-Attenuated

Figure 10. Product Picture of Inactivated

Figure 11. Product Picture of Recombinant Sub Unit and Toxoid

Figure 12. Global Disease Control and Prevention Vaccine Sales Market Share by Type in 2021

Figure 13. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2017-2022)

Figure 14. Disease Control and Prevention Vaccine Consumed in Pediatric Vaccine

Figure 15. Global Disease Control and Prevention Vaccine Market: Pediatric Vaccine (2017-2022) & (K Units)

Figure 16. Disease Control and Prevention Vaccine Consumed in Adult Vaccine

Figure 17. Global Disease Control and Prevention Vaccine Market: Adult Vaccine (2017-2022) & (K Units)

Figure 18. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2017-2022)

Figure 19. Global Disease Control and Prevention Vaccine Revenue Market Share by Application in 2021

Figure 20. Disease Control and Prevention Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Disease Control and Prevention Vaccine Revenue Market Share by Company in 2021

Figure 22. Global Disease Control and Prevention Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Disease Control and Prevention Vaccine Revenue Market Share by Geographic Region in 2021

Figure 24. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2017-2022)

Figure 25. Global Disease Control and Prevention Vaccine Revenue Market Share by Country/Region in 2021

Figure 26. Americas Disease Control and Prevention Vaccine Sales 2017-2022 (K Units)

Figure 27. Americas Disease Control and Prevention Vaccine Revenue 2017-2022 ($ Millions)

Figure 28. APAC Disease Control and Prevention Vaccine Sales 2017-2022 (K Units)

Figure 29. APAC Disease Control and Prevention Vaccine Revenue 2017-2022 ($ Millions)

Figure 30. Europe Disease Control and Prevention Vaccine Sales 2017-2022 (K Units)

Figure 31. Europe Disease Control and Prevention Vaccine Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Disease Control and Prevention Vaccine Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Disease Control and Prevention Vaccine Revenue 2017-2022 ($ Millions)

Figure 34. Americas Disease Control and Prevention Vaccine Sales Market Share by Country in 2021

Figure 35. Americas Disease Control and Prevention Vaccine Revenue Market Share by Country in 2021

Figure 36. United States Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Disease Control and Prevention Vaccine Sales Market Share by Region in 2021

Figure 41. APAC Disease Control and Prevention Vaccine Revenue Market Share by Regions in 2021

Figure 42. China Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Disease Control and Prevention Vaccine Sales Market Share by Country in 2021

Figure 49. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country in 2021

Figure 50. Germany Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Disease Control and Prevention Vaccine Revenue Market Share by Country in 2021

Figure 57. Egypt Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Disease Control and Prevention Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Disease Control and Prevention Vaccine in 2021

Figure 63. Manufacturing Process Analysis of Disease Control and Prevention Vaccine

Figure 64. Industry Chain Structure of Disease Control and Prevention Vaccine

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390